Rite Aid: The Opioid Warnings It Allegedly Deleted

Rite Aid’s opioid False Claims Act settlement called for a $7.5 million payment and a $401.8 million allowed unsecured bankruptcy claim to resolve allegations of unlawful dispensing and false reimbursement claims. The government alleged that pharmacists warned Rite Aid about suspicious prescribers and the company deleted their warnings from its dispensing software.

The Justice Department announced the settlement on July 10, 2024. This pharmaceutical fraud case began with claims brought by former Rite Aid employees who had worked at its pharmacies. The government joined part of their case, pursuing allegations under both the False Claims Act and the Controlled Substances Act.

What Are Red Flags for Pharmacists?

Red flags are warning signs involving a prescription, its prescriber or the customer. The government alleged that Rite Aid pharmacists ignored them, including prescriptions for excessive quantities of oxycodone and fentanyl, a dangerous drug combination known as the trinity, and prescriptions from practitioners they had repeatedly identified as suspicious.

The government’s complaint alleged that, from at least May 1, 2014, through June 10, 2019, Rite Aid filled at least hundreds of thousands of unlawful controlled-substance prescriptions. It described prescriptions that were medically unnecessary, lacked a medically accepted indication or fell outside the usual course of professional practice. The settlement also covered allegations that certain Washington pharmacies filled prescriptions from practitioners who lacked the proper controlled-substance prescribing authority.

Rite Aid operated more than 2,200 pharmacies in 17 states when the alleged conduct occurred. A warning entered at one pharmacy could matter beyond that counter. The complaint alleged that pharmacists made no effort, or a plainly inadequate effort, to resolve the red flags before dispensing.

The Warnings Reached Rite Aid From Inside and Outside

Rite Aid’s Government Affairs Department allegedly received warnings from its own pharmacists, its dispensing reports and its drug distributor. According to the complaint, pharmacists raised concerns about prescribers, the company’s data showed problematic prescribing patterns, and the distributor warned about the volume of drugs, particularly oxycodone, ordered for outlier Rite Aid stores.

The complaint alleged that the department disregarded all of them. Even when pharmacists reported that a practitioner was prescribing controlled substances without a legitimate medical purpose, Rite Aid allegedly rarely acted to stop that practitioner’s prescriptions from being filled. The information reached the department responsible for addressing it and, according to the government, largely sat there.

The Notes Allegedly Deleted From the Dispensing Software

The government alleged something more deliberate than leaving a warning unanswered. Its complaint described instructions to remove the warnings themselves:

The alleged response to a pharmacist’s concern was to change what other pharmacists could read. That is a different decision from the original decision to fill a prescription.

A 2020 University of Portsmouth doctoral thesis on pharmacists’ decision-making examined working pharmacists’ responses to hypothetical cases. It found:

A colleague’s recorded warning gives the next pharmacist information beyond an individual judgment call. In Rite Aid’s case, the government alleged that the company actively removed that information.

Why the Reimbursement Claim Mattered

The Justice Department alleged that knowingly dispensing unlawful controlled-substance prescriptions violated the Controlled Substances Act, and that seeking federal healthcare reimbursement for them also violated the False Claims Act.

The allegedly unlawful prescriptions put patients at risk, and the reimbursement claims passed the bill to taxpayers. The complaint tied those claims to prescriptions it described as medically unnecessary, lacking a medically accepted indication or issued outside the usual course of professional practice.

Bankruptcy Changed the Settlement’s Payment Terms

The bankruptcy court approved a promised payment and a separate claim against Rite Aid’s bankruptcy estate on June 28, 2024, as part of the company’s reorganization plan. The announcement set the former employees’ whistleblower share at 17% of the government’s False Claims Act recovery in this matter.

A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers.

The Separate Rite Aid and Elixir Rebate Settlement

Rite Aid and Elixir’s separate Medicare Part D settlement, announced the same day, carried a $101 million payment obligation and its own $20 million unsecured bankruptcy claim.

That case concerned manufacturer rebates allegedly reported as service fees, affecting Medicare’s reconciliation of plan payments. The opioid case concerned the prescriptions dispensed and the reimbursement sought for them.

The Controls Rite Aid Agreed to Change

The resolution also addressed how Rite Aid would review prescriptions and keep information about suspicious dispensing. Its agreement with the Drug Enforcement Administration called for additional employee training to identify illegitimate prescriptions and reduce diversion, better communication between the company, its retailers and the agency, and retention of materials relevant to agency investigations for at least five years.

The corporate integrity agreement with the Office of Inspector General of the Department of Health and Human Services included an independent review of whether prescription drugs were properly prescribed, dispensed and billed. That comparison reaches across the whole transaction: the prescription, what the pharmacy supplied and what it charged.

The Pharmacy Billing Pattern in the Walgreens Case

Walgreens later settled allegations involving invalid controlled-substance prescriptions and federal reimbursement in April 2025. Former employees had brought four qui tam cases resolved by that civil settlement.

The useful parallel is the relationship between dispensing and billing. In both matters, the government alleged that pharmacies filled invalid prescriptions and sought federal reimbursement for them. An employee’s knowledge of the prescription or the pharmacy’s response to a warning can explain a claim that otherwise appears to be an ordinary transaction. At Rite Aid, the complaint made that knowledge concrete through the pharmacists’ notes, the dispensing reports and the distributor’s warnings.

You Know What Happened to the Warning

If you saw a prescriber warning erased, a dispensing report ignored or questionable prescriptions sent for government payment, tell our whistleblower experts what happened inside the pharmacy. We connect your knowledge of the dispensing decisions to the payment evidence and build your strongest pharmacy whistleblower case with you. We bring in pharmaceutical whistleblower lawyers who understand pharmacy dispensing and federal reimbursement, and stay beside you throughout the case.